comparemela.com

Latest Breaking News On - Syros pharmaceuticals trading - Page 1 : comparemela.com

Syros Pharmaceuticals (NASDAQ:SYRS) Stock Price Passes Below 50 Day Moving Average of $5.94

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.94 and traded as low as $5.28. Syros Pharmaceuticals shares last traded at $5.44, with a volume of 199,560 shares traded. Wall Street Analysts […]

Piper-sandler
Syros-pharmaceuticals-inc
Syros-pharmaceuticals-trading
Opaleye-management-inc
News-ratings-for-syros-pharmaceuticals-daily
Syros-pharmaceuticals
Nasdaq
Flagship-pioneering-inc
Institutional-trading-of-syros-pharmaceuticals
Syros-pharmaceuticals-company-profile
Get-free-report
Partners-management

Syros Pharmaceuticals (NASDAQ:SYRS) Cut to Sell at StockNews.com

StockNews.com cut shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) from a hold rating to a sell rating in a report published on Tuesday morning. Separately, Piper Sandler dropped their price objective on shares of Syros Pharmaceuticals from $11.00 to $7.00 and set an overweight rating on the stock in a research report on Tuesday, […]

Piper-sandler
Srinivas-akkaraju
Syros-pharmaceuticals-inc
Renaissance-technologies
News-ratings-for-syros-pharmaceuticals-daily
Syros-pharmaceuticals-company-profile
Syros-pharmaceuticals
Syros-pharmaceuticals-trading
Insider-activity-at-syros-pharmaceuticals
Millennium-management
Institutional-investors-weigh-in-on-syros-pharmaceuticals

Syros Pharmaceuticals (NASDAQ:SYRS) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research note published on Thursday morning. The brokerage issued a hold rating on the stock. A number of other brokerages have also recently commented on SYRS. JMP Securities dropped their target price on Syros Pharmaceuticals from $16.00 to $15.00 in a […]

Piper-sandler
David-roth
Mirabella-financial-services
Institutional-investors-weigh-in-on-syros-pharmaceuticals
Securities-exchange-commission
Nasdaq
Syros-pharmaceuticals-inc
Syros-pharmaceuticals-trading
News-ratings-for-syros-pharmaceuticals-daily
Syros-pharmaceuticals
Insider-activity-at-syros-pharmaceuticals
Millennium-management

Q3 2023 EPS Estimates for Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Increased by Analyst

Q3 2023 EPS Estimates for Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Increased by Analyst
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

David-roth
Piper-sandler
Syros-pharmaceuticals-trading
Virtu-financial
Syros-pharmaceuticals-inc
News-ratings-for-syros-pharmaceuticals-daily
Syros-pharmaceuticals
Nasdaq
Pricet-rowe-associates-inc
Denali-advisors
Free-report
Syros-pharmaceutical
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.